Facebook Twitter Instagram YouTube Linkedin Contact

Choroideremia Research

September 21, 2018

Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.

Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia

 

In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.

If you have a question related to choroideremia, please contact us at 214-363-3911.

 

❮ News Articles
Share on: Facebook Twitter Linkedin
Choroideremia Research

Related Articles

Recently@Retina Newsletter January 2023 Exclusive: Retina Foundation Receives $1 Million Donation to Advance Ocular Stem Cell Lab Recently@Retina Newsletter November 2023 First Patient in Phase 1/2 Clinical Study of Gene Therapy is Treated for X-Linked RP What Does “Blindness” Really Mean?
Mailicon
Get the Latest Updates

Sign up to receive emails from Retina Foundation that will keep you up-to-date on our research and events.

  • This field is for validation purposes and should be left unchanged.
Contact Us

Contact Us

  • This field is for validation purposes and should be left unchanged.
x

Please check all that apply:

How did you learn about the
Retina Foundation?

  • This field is for validation purposes and should be left unchanged.
  • Please check all that apply:
Contact Us

Request an Appointment

Please complete this form if you are interested in speaking to a member of our team about your AMD.

all fields required

DOWNLOAD Printable Form